Topica Pharmaceuticals Presents Findings From Phase 1/2 Trial of Luliconazole Solution, 10% in Onychomycosis at ICAAC 2012
9/14/2012 9:05:39 AM
More...
|
Topica Pharmaceuticals Initiates Phase 2b/3 Study of Luliconazole in Patients With Onychomycosis of the Toenails
6/27/2012 9:05:21 AM
More...
|
Topica Pharmaceuticals Presents Promising Luliconazole Solution, 10% Data in Onychomycosis at 2012 American Academy of Dermatology Annual Meeting
3/19/2012 8:41:40 AM
More...
|
Topica Pharmaceuticals Names Dr. Amir Tavakkol Senior Vice President of Clinical Development and Operations
12/5/2011 9:07:29 AM
More...
|
Geron Corporation (GERN): A Tribute to Alex Barkas
11/23/2011 10:06:47 AM
More...
|
Topica Pharmaceuticals Announces Completion of $27 Million Series B Financing
10/18/2011 6:52:48 AM
More...
|
Topica Pharmaceuticals Announces Positive Results From Phase 1/2a Trial of Luliconazole for Treatment of Onychomycosis
6/20/2011 10:10:50 AM
More...
|
Topica Pharmaceuticals Announces Appointment of David E. Cohen, M.D., to Board of Directors
3/28/2011 9:31:13 AM
More...
|
Topica Pharmaceuticals Announces Enrollment of First Patient in Phase 1/2a Trial of Luliconazole for Treating Onychomycosis
1/11/2011 8:48:12 AM
More...
|
Topica Pharmaceuticals Announces Sublicensing Agreement for Tinea Indication
9/21/2010 8:32:51 AM
More...
|
|